- Telbivudine-Induced Myopathy: Clinical Features, Histopathological Characteristics, and Risk Factors
-
Lan MY, Lin HCL, Hu TH, Chen SFC, Chen CH, Chang YY, Chiu KW, Lin TK, Chen SS
- KMID: 2537184
- J Clin Neurol.
- 2023 Jan;19(1):52-59.
- doi: 10.3988/jcn.2023.19.1.52
Background and Purpose Oral nucleos(t)ide analogs (NAs) are the mainstay treatment for chronic hepatitis B (CHB). Myotoxicity is an important extrahepatic effect related to NA treatment. Telbivudine is the NA... -
- CITED
-
- Close
- SHARE
-
- Close
